Literature DB >> 14766408

B cells in multiple sclerosis.

Mark P Burgoon1, Donald H Gilden, Gregory P Owens.   

Abstract

The most common laboratory abnormality in multiple sclerosis (MS) is an increased amount of cerebrospinal fluid IgG and the presence of oligoclonal bands. Despite studies of the humoral response that suggest the involvement of an infectious agent or autoantigen in disease, the major targets of the oligoclonal response are still unknown. Identification of these targets will reveal valuable insights into the cause and pathogenesis of MS and is likely to lead to effective treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766408      PMCID: PMC3291127          DOI: 10.2741/1278

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  121 in total

1.  Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis.

Authors:  M Cruz; T Olsson; J Ernerudh; B Höjeberg; H Link
Journal:  Neurology       Date:  1987-09       Impact factor: 9.910

2.  Humoral immunity in chronic relapsing experimental autoimmune encephalomyelitis. The major oligoclonal IgG bands are antibodies to mycobacteria.

Authors:  P Glynn; D Weedon; J Edwards; A J Suckling; M L Cuzner
Journal:  J Neurol Sci       Date:  1982-12       Impact factor: 3.181

Review 3.  The genetics of susceptibility to multiple sclerosis.

Authors:  R S Spielman; N Nathanson
Journal:  Epidemiol Rev       Date:  1982       Impact factor: 6.222

4.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

5.  Antibodies against oligodendrocytes in serum and CSF in multiple sclerosis and other neurological diseases: 125I-protein A studies.

Authors:  A J Steck; H Link
Journal:  Acta Neurol Scand       Date:  1984-08       Impact factor: 3.209

6.  Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis.

Authors:  C V Sumaya; L W Myers; G W Ellison; Y Ench
Journal:  Ann Neurol       Date:  1985-04       Impact factor: 10.422

7.  Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS.

Authors:  C H Chou; W W Tourtellotte; R F Kibler
Journal:  Neurology       Date:  1983-01       Impact factor: 9.910

8.  Intrathecal antibody synthesis to virus antigens in multiple sclerosis.

Authors:  A Salmi; M Reunanen; J Ilonen; M Panelius
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

9.  The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane.

Authors:  R Lebar; C Lubetzki; C Vincent; P Lombrail; J M Boutry
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

10.  Lipid/myelin basic protein multilayers. A model for the cytoplasmic space in central nervous system myelin.

Authors:  J Sedzik; A E Blaurock; M Höchli
Journal:  J Mol Biol       Date:  1984-04-05       Impact factor: 5.469

View more
  4 in total

1.  Recombinant antibodies generated from both clonal and less abundant plasma cell immunoglobulin G sequences in subacute sclerosing panencephalitis brain are directed against measles virus.

Authors:  Mark P Burgoon; Yupanqui A Caldas; Kathryne M Keays; Xiaoli Yu; Donald H Gilden; Gregory P Owens
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

2.  Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies.

Authors:  Mark P Burgoon; Kathryne M Keays; Gregory P Owens; Alanna M Ritchie; Pradeep R Rai; Carlyne D Cool; Donald H Gilden
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

Review 3.  Pathology of multiple sclerosis: where do we stand?

Authors:  Bogdan F Gh Popescu; Istvan Pirko; Claudia F Lucchinetti
Journal:  Continuum (Minneap Minn)       Date:  2013-08

Review 4.  Role of SIRT1 in autoimmune demyelination and neurodegeneration.

Authors:  Alvaro Martin; Cosmin A Tegla; Cornelia D Cudrici; Adam M Kruszewski; Philippe Azimzadeh; Dallas Boodhoo; Armugam P Mekala; Violeta Rus; Horea Rus
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.